Immediate release and sustained release ibuprofen dosing regimen
View Patent ↗A method of administering non-steroidal-anti-inflammatory drugs, in particular propionic acid derivatives such as ibuprofen, is provided. The inventive dosage forms provide an initial release of the NSAID and a second sustained release of NSAID, preferably in a single dosing step.
1. A method of reducing fever over a 12 hour period, comprising administering to a mammal in need thereof a dosage form comprising an immediate release portion comprising about 200 mg to about 400 mg of an immediate release dose of ibuprofen, wherein said immediate release dose is released at the beginning of said 12 hour period, and a sustained release portion comprising about 100 mg to about 200 mg of a sustained release dose of said ibuprofen, wherein said sustained release dose is released at about 2 hours to about 10 hours after release of said immediate release dose, and wherein said immediate release portion contains a dose that is at least about twice the dose in the sustained release portion.
2. The method of claim 1 , wherein said ibuprofen has a duration of therapeutic effect which lasts at least about 6 hours after release of said sustained release dose.
3. The method of claim 1 , wherein the sustained release dose is zero-order.
4. The method of claim 1 , wherein the sustained release dose is first-order.
5. The method of claim 1 , wherein said immediate release dose provides about 5.7 mg/kg to about 12 mg/kg of ibuprofen and said sustained release dose provides about 2.5 mg/kg to about 4 mg/kg of ibuprofen.
6. The method of claim 1 , wherein said immediate release dose provides about 5.7 mg/kg of ibuprofen and the sustained release dose provides about 2.86 mg/kg of ibuprofen.